Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lab-on-a-Chip Technology Requires Standardization

By LabMedica International staff writers
Posted on 23 Aug 2012
Testing standards need to be developed and implemented before Lab-on-a-Chip (LOC) technology can be fully commercialized. More...


LOC devices are microchip-size systems, that can prepare and analyze tiny fluid samples with volumes ranging from a few microliters to sub-nanoliters, are envisioned to one day revolutionize how laboratory tasks such as diagnosing diseases are performed.

Physical scientists at the US National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA) have suggested that standardized testing and measurement methods, will enable microelectromechanical systems (MEMS) LOC manufacturers at all stages of production, from processing of raw materials to final rollout of products, to accurately determine important physical characteristics of LOC devices such as dimensions, electrical surface properties, and fluid flow rates and temperatures.

To make the case for testing standards, the scientists have focused on autofluorescence, the background fluorescent glow of an LOC device that can interfere with the analysis of a sample. Multiple factors must be considered in the development of a testing standard for autofluorescence, including the materials used in the device, the measurement methods used to test the device, and how the measurements are interpreted. This material property of microfluidic and nanofluidic devices is of increasing importance due to the growing interest in sensitive fluorescence measurements performed in chips fabricated from plastics

Samuel M. Stavis, PhD, the author of the study, said: "Quality control during LOC device manufacturing may require different tests of autofluorescence throughout the process. There may be one measurement of autofluorescence from the block of plastic that is the base material for a chip, another once the block has been fashioned into the substrate in which the functional components are embedded, and yet another as the final device is completed. To manufacture lab on a chip devices with reliably low autofluorescence, accurate measurements may be needed at each stage."

Dr. Stavis emphasizes that it is important not to confuse testing standards with product standards, and to understand how the former facilitates the latter. He added, "A product standard specifies the technical requirements for a lab-on-a-chip device to be rated as top quality. A testing standard is needed to measure those specifications, as well as to make fair comparisons between competing products." The study was published on June 28, 2012, in the journal Lab on A Chip.

Related Links:

US National Institute of Standards and Technology



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.